Structured assessment of drug-drug interactions;Gestructureerde beoordeling van geneesmiddeleninteracties

Pharmaceutisch Weekblad

Volumn 137, Issue 7, 2002, Pages 255-260

  Van Roon, E N ^a   Kerremans, A ^a   Flikweert, S ^a   Kwee Zuiderwijk, W J M ^a   Le Comte, M ^a   Brouwers, J R B J ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Classification; Drug interactions; Medical informatics; Medication surveillance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMIODARONE; ANTIRETROVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOZAPINE; CORTICOSTEROID; CYCLOSPORIN; DIGOXIN; DOXYCYCLINE; ERGOTAMINE; ITRACONAZOLE; KETOCONAZOLE; LEVODOPA; LITHIUM; METHOTREXATE; MYCOPHENOLIC ACID; OLANZAPINE; PHENYTOIN; QUINIDINE; TACROLIMUS; TERFENADINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALYTIC METHOD; ARTICLE; COMPUTER ANALYSIS; COMPUTER PROGRAM; DRUG COMPETITION; DRUG MONITORING; HEALTH CARE ORGANIZATION; REPRODUCIBILITY;

EID: 0037083304     PISSN: 00316911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kwaliteitsaspecten van farmacotherapie
2. Interacties van geneesmiddelen: Achtergronden en klinische betekenis
3. Omgaan met geneesmiddeleninteracties
4. Drug-drug interactions related to hospital admissions in older adults: A prospectove study of 1000 patients
5. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population
6. A medication database - A tool for detecting drug interactions in hospital
7. Quantifying the clinical significance of drug-drug interactions: Scaling pharmacists' perceptions of a common interaction classification scheme
8. FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: Impact on labeling
9. Amiodarone and phenytoin: Interaction
10. Amiodarone-phenytoin interaction
11. Possible interaction between amiodarone and phenytoin
12. Steady-state interaction between amiodarone and phenytoin in normal subjects
13. Effect of phenytoin on the clinical pharmacokinetics of amiodarone